What is the recommended approach to assess and treat an adolescent with psychosis?

Working with Adolescents with Psychosis

Provide timely, flexible assessment in outpatient or home settings when safe, initiate low-dose atypical antipsychotics (risperidone 2 mg/day or olanzapine 7.5-10 mg/day), and immediately involve families in treatment planning while arranging psychoeducation and cognitive-behavioral therapy. 1

Initial Assessment Approach

Location and Timing

Deliver assessment in user-friendly, accessible settings—preferably outpatient clinics or the patient's home—unless safety concerns necessitate hospitalization 1. Assessment should be timely based on urgency and flexible regarding location 1.

Rule Out Medical Causes First

Before diagnosing primary psychosis, screen for physical illnesses that can cause psychotic symptoms 1. The diagnostic yield of extensive medical workup is low (1.3% in recent data), but focus on:

• Urine toxicology (identifies substance-related causes in 8.1% of cases, predominantly cannabinoids) 2
• Corticosteroid use (documented cause of psychosis) 2
• Neuroimaging only if: neurological abnormalities present or atypical clinical features exist 2
• EEG: rarely identifies psychosis etiology without neurological signs 2

Younger children require more comprehensive medical evaluation as non-psychiatric conditions (epilepsy, infections, metabolic disorders, immunologic conditions) are more likely to simulate schizophrenia 3.

Safety Assessment

Immediately evaluate suicide risk—suicide remains a persistent peril for individuals with psychosis 3. Assess for:

• Self-harm risk
• Aggression toward others
• Level of community support available
• Family's capacity to manage the crisis 1

When to Hospitalize

Admit to inpatient care if:

• Significant risk of self-harm exists
• Aggression poses danger to others
• Community support is insufficient
• Crisis severity exceeds family's ability to cope 1

In-patient units should be small, adequately staffed, with frequent risk assessment 1.

Pharmacological Treatment

First-Line Medication Strategy

Start with atypical antipsychotics at low doses to minimize extrapyramidal side effects and encourage future adherence 1:

Initial target doses:

• Risperidone: 2 mg/day 1
• Olanzapine: 7.5-10 mg/day 1

Maximum doses for first-episode psychosis:

• Risperidone: 4 mg/day 1
• Olanzapine: 20 mg/day 1
• Haloperidol equivalent: 4-6 mg/day (though atypical agents preferred) 1

Dosing Principles

• After initial titration, increase doses only at widely spaced intervals (14-21 days) if response inadequate 1
• Increase only within limits of sedation and extrapyramidal side effects 1
• Avoid extrapyramidal side effects to encourage adherence—typical antipsychotics are less well tolerated even at low doses 1
• Low doses will not have rapid effect on distress; patience is required 1

Treatment-Resistant Cases

If positive symptoms persist after trials of two first-line atypical antipsychotics (approximately 12 weeks), review reasons for treatment failure 1. Clozapine remains the gold standard for drug-resistant schizophrenia despite its concerning side effect profile (agranulocytosis, seizures, sialorrhea) 3.

Monitoring Requirements

Implement structured pharmacological monitoring for metabolic side effects—youth are particularly vulnerable to adverse metabolic events 4. Many adolescents do not respond adequately to available agents and experience significant side effects 4.

Psychosocial Interventions (Essential, Not Optional)

Family Involvement

Include families in assessment and treatment planning from the outset 1. This is non-negotiable:

• Families are usually in crisis at treatment initiation 1
• Provide emotional support and practical advice 1
• Offer family interventions and psychoeducation 1, 5
• Help families develop coping skills 1

Evidence-Based Psychotherapy

Provide cognitive-behavioral therapy adapted for adolescent developmental needs 5, 6:

• Tailor assessment, formulation, and interventions to developmental stage 6
• Use developmentally appropriate techniques and resources 6
• This approach is acceptable, safe, and helpful for young people with psychosis 6

Additional Psychosocial Components

• Psychoeducation (strongly endorsed) 5
• Supported education and employment 5
• Cognitive remediation 7
• Specific crisis management strategies for patients and families 1

Service Delivery Model

Specialized Care Structure

Provide care through specialized multidisciplinary teams with:

• Assertive and continuous follow-up 5
• Dedicated pathways for early psychosis 5
• Comprehensive multidisciplinary assessment 5

Assessment of Negative Symptoms

Evaluate five distinct domains using dedicated scales like the BNSS 7:

• Anhedonia
• Asociality
• Alogia
• Avolition
• Blunted affect

Distinguish primary from secondary negative symptoms for accurate treatment targeting 7.

Critical Pitfalls to Avoid

1. Don't use typical antipsychotics as first-line: Even at low doses, they cause more extrapyramidal effects and reduce adherence 1

2. Don't increase doses too quickly: Wait 14-21 days between increases after initial titration 1

3. Don't exclude families: They are essential partners, not obstacles 1

4. Don't order extensive medical workup without clinical indication: Neuroimaging and EEG have minimal yield without neurological signs 2

5. Don't rely on medication alone: Psychosocial interventions are essential components, not adjuncts 1, 5

6. Don't miss substance use: Screen with urine toxicology, particularly for cannabinoids 2

7. Don't ignore developmental stage: Adolescents have distinct needs requiring adapted therapeutic approaches 6